Wire · opportunities
Abbott receives FDA approval for new CardioMEMS HF System capabilities that help ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 5 October 2026 · Fusion42 review
Abbott received FDA approval for new capabilities in the CardioMEMS HF System that allow patients to view their pulmonary artery pressure readings and receive medication updates via the CardioGuide HF App, enhancing patient engagement and early heart failure management.
This Wire brief sits within Fusion42's coverage of Digital Health, and 5 sources have reported it between 5 Oct 2026 and 8 Oct 2026.
◆ ◆ The Wire takeaway
You can now build deeper patient engagement tools as Abbott’s app opens access to critical heart failure data. This approval shifts some care responsibility onto patients, creating a need for apps that provide clear guidance and support.
◆ Coverage
5 sources · first reported 5 Oct 2026 · latest 8 Oct 2026
◆ Related on Wire
◆ Topics